Evidence map›Paper›PMID 24834110›Full record

ArticleInfectious agents and cancer2014

High viral load of Merkel cell polyomavirus DNA sequences in Langerhans cell sarcoma tissues.

Ichiro Murakami, Michiko Matsushita, Takeshi Iwasaki, Satoshi Kuwamoto, Masako Kato, Yasushi Horie, Kazuhiko Hayashi, Jean Gogusev, Francis Jaubert, Shu Nakamoto and 5 more

Open access · goldAbstract read
In one paragraph

Article in Infectious agents and cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Merkel cell polyomavirus and Langerhans cell neoplasm.Cell communication and signaling : CCS · 2018
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Ichiro MurakamiDivision of Molecular Pathology, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan.
Michiko MatsushitaDepartment of Pathobiological Science and Technology, School of Health Science, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan.
Takeshi IwasakiDivision of Molecular Pathology, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan.
Satoshi KuwamotoDivision of Molecular Pathology, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan.
Masako KatoDivision of Molecular Pathology, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan.
Yasushi HorieDepartment of Pathology, Tottori University Hospital, Yonago 683-8503, Japan.
Kazuhiko HayashiDivision of Molecular Pathology, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan.
Jean GogusevInserm U507 and U1016, Institut Cochin, Paris 75014, France.
Francis JaubertUniversity of Paris Descartes (Paris V), Paris 75006, France.
Shu NakamotoDepartment of Pathology, Tottori Prefectural Central Hospital, Tottori 680-0901, Japan.
Mitsunori YamakawaDepartment of Pathological Diagnostics, Yamagata University School of Medicine, Yamagata 990-9585, Japan.
Hirokazu NakamineDepartment of Laboratory Medicine, The Japan Baptist Medical Foundation, Kyoto 606-8273, Japan.
Katsuyoshi TakataDepartment of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8530, Japan.
Takashi OkaDepartment of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8530, Japan.
Tadashi YoshinoDepartment of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8530, Japan.
Tottori University · JPOkayama University · JPInstitut Cochin · FRTottori Prefectural Central Hospital · JPTottori University Hospital · JPUniversité Paris Cité · FRYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLangerhans cell (LC) sarcoma (LCS) is a high-grade neoplasm with overtly malignant cytologic features and an LC phenotype. We very recently suggested that LC behaves as a reservoir for common dermotropic Merkel cell polyomavirus (MCPyV) and determined the relationship between LC histiocytosis (LCH), which has an underlining oncogenic capacity, and MCPyV as a trigger for a reactive process rather than a neoplastic process. We propose LC to be a reservoir for MCPyV and hypothesize that some LCS subtypes may be related to the MCPyV agent.

findingsWe examined seven LCS tissues using multiplex quantitative PCR (Q-PCR) and immunohistochemistry with anti MCPyV large-T (LT) antigen antibody. High viral loads of MCPyV DNA sequences (viral load = relative levels of MCPyV) were detected (0.328-0.772 copies/cell (Merkel cell carcinoma (MCC) = 1.0)) using Q-PCR in 43% (3/7) tissues, but LT antigen expression was not observed (0/7).

conclusionsFrequent MCPyV-DNA amplification suggests that LCS in some patients may be related to MCPyV infection. Moreover, the higher viral load of LCS (median, 0.453 copies/cell) than low load of LCH (0.003, median of 12 cases) (P < 0.01) may suggest a virally induced tumorigenic process in some LCS. Although the absence of LT antigen expression may indicate a different role for MCPyV in this pathology, some subtypes of LCS may develop in the background of MCPyV-infected LC. To the best of our knowledge, this is the first report on the relationship between MCPyV and LCS. The recent discovery of MCPyV opened new therapeutic avenues for MCC. These data open novel possibilities for therapeutic interventions against LCS.

Indexed as

Langerhans cellLangerhans cell sarcomaMerkel cell polyomavirusMultiplex quantitative PCR

Identifiers

PMID24834110
PMCPMC4022531
OpenAlexW2171113859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.